Contact with other specified venomous plants

VWXY20_CONTACT_W_OTHER_SPECIFE_VENOMO_PLANTS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X28 Cause of death: ICD-10 — X28 2 out of 7 registries used, show all original rules.	34
4. Check minimum number of events None	34
5. Include endpoints None	34
6. Filter based on genotype QC (FinnGen only)	34

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X20-X29

NAME	VWXY20_CONTACT_W_OTHER_SPECIFE_VENOMO_PLANTS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X28
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X28
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Contact with other specified venomous plants based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	34	23	11
Unadjusted period prevalence (%)	0.01	0.01	0.00
Median age at first event (years)	38.38	47.11	20.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

2.95

1.73

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2.94

1.63

2.4

2.3

2.42

mmol/l

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

104

2.27

1.46

3.4

3.9

37.45

36.05

g/l

0.78

(3026008) Bacteria identified in Urine by Culture

2.26

1.34

2.1

2.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2.26

1.29

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

148

2.10

1.20

2.3

3.4

6.33

6.25

mmol/l

0.08

139

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

205

2.14

1.17

7.1

6.3

76.62

76.41

u/l

0.01

188

(3015736) pH of Urine

2.07

1.14

3.1

2.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2.04

1.10

3.8

3.1

19.13

20.61

ng/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.00

1.03

0.0

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.00

1.01

0.0

2.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2.11

1.01

2.3

27097.30

9042.02

umol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

201

1.92

0.85

3.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1.86

0.82

3.0

3.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.00

0.78

1.4

1.3

—

(3019225) pH of Specimen

2.26

0.78

4.8

4.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1.75

0.75

4.6

3.0

—

(40768797) Stomach Pathology biopsy report

1.99

0.71

1.6

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

177

1.69

0.66

5.0

4.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1.69

0.65

2.2

1.7

96.17

107.68

pmol/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.62

0.0

1.5

—

(3013512) EKG study

1.61

0.60

5.6

3.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1.66

0.57

4.6

2.7

—

(42870588) Differential panel, method unspecified - Blood

1.59

0.51

7.0

4.9

—

(3019150) Specific gravity of Urine by Refractometry

1.50

0.48

2.6

3.1

—

1.01

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.55

0.42

1.8

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.42

0.0

1.4

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.42

0.0

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.42

0.0

1.4

—

(40758558) Short blood count panel - Blood

0.58

0.41

3.6

5.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.50

0.41

5.4

6.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.41

0.0

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.41

0.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.41

0.0

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

140

1.43

0.38

4.3

5.6

7.96

10.79

umol/l

1.89

131

(3003338) MCHC [Mass/volume]

233

1.49

0.36

16.3

14.2

335.04

332.64

g/l

0.75

233

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1.46

0.36

2.6

2.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.43

0.34

3.9

3.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.22

0.0

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

0.00

0.22

0.0

5.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.22

0.0

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.22

0.0

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.22

0.0

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.22

0.0

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

0.00

0.22

0.0

3.0

—

24.46

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.3

—

(3000991) Gas panel - Venous blood

0.00

0.21

0.0

3.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.6

—

0.93

—

(3023368) Bacteria identified in Blood by Culture

1.23

0.19

4.0

3.4

—

(3018095) Leukocytes [#/volume] in Urine

1.29

0.19

2.8

3.4

12.32

101.49

e6/l

—

(36304419) Bacteria [Presence] in Urine

1.19

0.18

2.0

2.8

—

(1761868) Lipid panel - Serum or Plasma

0.78

0.17

2.6

2.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

256

1.26

0.17

14.7

11.9

36.36

40.51

0.76

195

(3003694) ABO and Rh group [Type] in Blood

1.15

0.17

1.8

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.16

0.09

2.5

2.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

0.79

0.09

4.8

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.16

0.09

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

268

1.25

0.08

13.4

11.3

139.07

139.79

mmol/l

0.72

258

(3023103) Potassium [Moles/volume] in Serum or Plasma

268

1.25

0.08

13.6

11.6

3.88

3.93

mmol/l

0.45

258

(3044640) Blood type and Crossmatch panel - Blood

0.83

0.08

3.7

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.06

0.08

1.4

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

124

0.95

0.00

4.6

4.0

—

(3044889) 12 lead EKG panel

167

1.04

0.00

3.1

—

(40768804) Tissue Pathology biopsy report

109

1.01

0.00

2.1

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.8

—

(3039000) Anion gap in Blood

0.00

0.0

6.8

—

10.80

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

0.00

0.0

2.4

—

24.43

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

0.0

2.7

—

(4281824)

0.00

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.2

—

(3018572) Chloride [Moles/volume] in Blood

0.00

0.0

6.8

—

104.80

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

21.80

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

1.3

—

5.43

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.02

0.00

2.6

2.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

4.2

—

14.83

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.92

0.00

1.5

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.0

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.0

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

1.04

0.00

3.0

3.5

82.00

96.36

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.0

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

1.47

—

(3049717) Cytology report of Urine Cyto stain

0.00

0.0

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.04

0.00

2.0

2.5

343.33

1340.40

ng/l

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

1.3

—

61.50

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

27.27

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_CONTACT_W_OTHER_SPECIFE_VENOMO_PLANTS – Contact with other specified venomous plants

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Contact with other specified venomous plants

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Contact with other specified venomous plants (VWXY20_CONTACT_W_OTHER_SPECIFE_VENOMO_PLANTS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints